We could soon be approaching a time where personal cancer vaccines can be tailored to fight an individual patient’s tumor. Two early-stage human clinical trials have successfully used computer algorithms to choose the specific tumor cells that must be killed in order to treat the cancer. Using that information, the researchers could develop personalized cancer vaccines for patients. In one clinical trial, two-thirds of patients displayed no recurrence of their cancer 25 months after vaccination.